ESHAP

ESHAP is an acronym for relatively intensive chemotherapy regimen that is used for salvage therapy in relapsed or refractory lymphomas and Hodgkin lymphoma.

Uses your system voice; voice and rate in settings.

≈ 2 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

ESHAP is an acronym for relatively intensive chemotherapy regimen that is used for salvage therapy in relapsed or refractory lymphomas and Hodgkin lymphoma. In combination with monoclonal antibody Rituximab it is called R-ESHAP or ESHAP-R.[1]

R-ESHAP consists of:

  1. Rituximab, an anti-CD20-directed monoclonal antibody that kills both normal and malignant B-lymphocytes
  2. Etoposide, an epipodophyllotoxin topoisomerase inhibitor
  3. Solu-Medrol - Methylprednisolone, which is a glucocorticoid that can lyse lymphocytes
  4. High-dose Ara-C - cytarabine
  5. Platinol - Cisplatin, a platinum-based antineoplastic agent, also an alkylating antineoplastic agent.

Dosing regimen

edit edit source
Drug Dose Mode Days
Rituximab 375 mg/m2 IV infusion Day 0
Etoposide 40 mg/m2 IV infusion over 1 hr Days 1-4
Solu-Medrol - Methylprednisolone 500 mg IV bolus over 15 min Days 1-5
High-dose Ara-C — cytarabine 2000 mg/m2 IV infusion over 2 hrs Day 5
Platinol (cisplatin) 25 mg/m2 IV continuous infusion over 24 hrs Days 1-4

References

edit edit source
  1. ^ ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. Wikipedia revision 1294953504, retrieved 2026-11-19

Text derived from https://en.wikipedia.org/w/index.php?oldid=1294953504 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001294953504 · captured 2025-06-10 · ledger · version history

Cite this page as: encyclopegia.org, “ESHAP”, snapshot enwiki-001294953504. https://encyclopegia.org/a/eshap